Announcements Trials

Browse Landscape

Phase

Status

Completed 6 Terminated 2 Active not recruiting 2 Unknown 1 Recruiting 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Carcinoma, Non-Small-Cell Lung 6 Neoplasms 2 Colorectal Neoplasms 2 Uveal Melanoma 1 Rare Tumor 1 Neoplasm Metastasis 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Non-Hodgkin 1 Lung Neoplasms 1

Interventions

pembrolizumab 49 Carboplatin 44 Magnetic Resonance Spectroscopy 40 Specimen Handling 39 Pemetrexed 35 Cisplatin 26 Blood Specimen Collection 25 durvalumab 17 Paclitaxel 17 osimertinib 15 Radiosurgery 15 Bevacizumab 15 Radiotherapy 14 Nivolumab 14 Gemcitabine 14 atezolizumab 13 Biopsy 13 Drug Therapy 12 Docetaxel 11 130-nm albumin-bound paclitaxel 11 Immunoglobulin G 10 X-Rays 9 Taxes 9 Standard of Care 9 Practice Guidelines as Topic 9 Educational Status 9 Disulfides 9 tislelizumab 8 Etoposide 8 Cetuximab 8

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Recruiting × Lung Neoplasms × Crizotinib × Clear all

NCT06563999 2026-04-21

NUMER

Sun Yat-sen University

Phase 2 Recruiting

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡